|
|
|
|
Vol. 57, Issue 1, 93-100, January 2000
in Controlling Hepatic Catalase Activity
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan
Mice deficient in hepatocyte nuclear factor 1
(HNF-1
) develop
Laron dwarfism and non-insulin-dependent diabetes mellitus (Lee et al.,
1998). Oxidative stress was present in the diabetic HNF-1
-null mice.
To understand the mechanism underlying the oxidative stress in
HNF-1
-null mice, we examined whether HNF-1
deficiency affects the
integrity of the cellular defense system against oxidative stress. The
glutathione level and activities of superoxide dismutase and
glutathione reductase in liver and other tissues examined were not
affected by HNF-1
deficiency. However, activities of cytosolic
glutathione peroxidase and catalase, two enzymes responsible for
detoxification of hydrogen peroxide within cells, were reduced specifically in liver of HNF-1
-null mice. The mRNA and protein levels of hepatic catalase in HNF-1
-null mice did not differ from
those in normal mice. The loss of hepatic catalase activity in
HNF-1
-null mice is probably caused by an insufficient heme pool in
liver cells, because the mRNA level of ferrochelatase, the enzyme that
catalyzes the last step of heme biosynthesis, was significantly reduced
in liver, and the daily hemin treatment restored partial catalase
activity in liver of HNF-1
-null mice. Furthermore, our results of
cell transfection and luciferase reporter assay indicated that the
mouse ferrochelatase promoter could be trans-activated directly by HNF-1
.
This article has been cited by other articles:
![]() |
Y.-H. Lee, M. A. Magnuson, V. Muppala, and S.-S. Chen Liver-Specific Reactivation of the Inactivated Hnf-1{alpha} Gene: Elimination of Liver Dysfunction To Establish a Mouse MODY3 Model Mol. Cell. Biol., February 1, 2003; 23(3): 923 - 932. [Abstract] [Full Text] |
||||
![]() |
H. Schrem, J. Klempnauer, and J. Borlak Liver-Enriched Transcription Factors in Liver Function and Development. Part I: The Hepatocyte Nuclear Factor Network and Liver-Specific Gene Expression Pharmacol. Rev., March 1, 2002; 54(1): 129 - 158. [Abstract] [Full Text] [PDF] |
||||